Abbreviations & Acronyms AGR = albumin: globulin ratio ALB = albumin BMI = body mass index CI = confidence interval CIS = carcinoma in situ CRP = C-reactive protein CSS = cancer-specific survival GLB = globulin Hgb = hemoglobin HR = hazard ratio IL = interleukin IQR = interquartile range NLR = neutrophil: lymphocyte ratio OS = overall survival RFS = recurrence-free survival RNU = radical nephroureterectomy ROC = receiver operating characteristic UTUC = upper tract urothelial carcinoma Objectives: To elucidate the effects of the preoperative albumin : globulin ratio on the survival of patients with upper tract urothelial carcinoma after radical nephroureterectomy. Methods: We retrospectively reviewed 124 consecutive patients with upper tract urothelial carcinoma who underwent radical nephroureterectomy at Chiba Cancer Center, Chiba, Japan between 2002 and 2015. The albumin : globulin ratio was defined: albumin / (total protein À albumin). Associations between preoperative clinicopathological factors, including the albumin : globulin ratio, and recurrence-free survival, cancer-specific survival and overall survival were assessed. The log-rank test and Cox proportional hazards models were used for univariate and multivariable analyses, respectively. The study cohort was separated into two groups based on the optimal albumin : globulin ratio cut-off value determined using receiver operating characteristic curve analysis. Results: The median survival time was 55 months (interquartile range 28-76 months), and 31 patients died during follow up. A low preoperative albumin : globulin ratio <1.40 was associated with tumor grade and surgical margin status. Kaplan-Meier analyses showed that a low albumin : globulin ratio was more significantly correlated with worse recurrence-free survival, cancer-specific survival and overall survival. Multivariate analyses showed that a low albumin : globulin ratio was an independent predictive factor associated with poor recurrence-free survival (hazard ratio 3.758; P = 0.0028), cancer-specific survival (hazard ratio 5.687; P = 0.0044) and overall survival (hazard ratio 3.124; P = 0.0030). Conclusions: A low albumin : globulin ratio is an independent predictive factor associated with poor prognosis in upper tract urothelial carcinoma patients treated with radical nephroureterectomy.
Introduction UTUC is relatively rare, accounting for just 5-10% of all urothelial carcinomas, and it has a poor prognosis. 1, 2 UTUC that invades the muscle wall usually has a poor prognosis. RNU is the gold standard treatment for UTUC.
Several risk factors, including patient's age and sex, tumor's size, BMI, and preoperative anemia, impact on patients' outcomes after RNU. [3] [4] [5] [6] [7] A tumor's stage and grade are wellknown prognostic factors that are associated with survival, and have been validated in several studies. [8] [9] [10] Although the precise prognosticators remain controversial, evidence is accumulating that suggests that a patient's nutritional status and the systemic inflammatory response could be important in relation to the development and progression of malignant tumors.
as ALB / (total protein À ALB), is an independent prognostic factor in patients with breast cancer, nasopharyngeal carcinomas and colorectal cancer. [14] [15] [16] Although the AGR might be an independent risk factor for UTUC, its significance as a predictive marker in patients with UTUC remains unclear. In the present study, we evaluated the significance of the preoperative AGR for predicting survival in patients with UTUC. 
Methods

Study population
We retrospectively reviewed 142 patients who underwent RNU at the University of Chiba's Cancer Center in Chiba, Japan, between January 2002 and December 2015. A total of 18 patients whose laboratory data were incomplete were excluded from the study, and the study cohort comprised 124 patients. This study was approved by the organization's institutional review board (H29-J029). Informed consent was obtained from all the individuals who participated in this study.
Study variables
The patients' medical charts were reviewed and data describing different clinical parameters, including age, sex, BMI, smoking history, history of bladder cancer, a tumor's laterality, the type of surgery and the use of adjuvant systemic chemotherapy, were collected. Blood tests were carried out within 1 month before surgery. None of the patients had active infections. The AGR was calculated as follows: AGR = ALB (total serum protein À ALB). All the surgical specimens were reviewed by dedicated genitourinary pathologists. The tumors were restaged and graded using the World Health Organization's 2016 classification.
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Treatment and follow up
Open (n = 80) and laparoscopic (n = 44) procedures were undertaken using the transperitoneal or retroperitoneal approach. Each physician determined whether a regional lymphadenectomy was carried out and its extent. Adjuvant chemotherapy was offered to patients with muscle-invasive disease and lymph node-positive disease, after considering their comorbidities, performance status and their willingness to accept therapy. After the RNUs, the follow-up examinations generally involved routine blood tests and computed tomography scans every 3 months for the first 2 years, after which the blood tests and scans were carried out every 6 months until 5 years had passed, and they were carried out annually thereafter.
Statistical analysis
The study's primary end-points were RFS, CSS and OS. Non-invasive bladder recurrences were excluded from the RFS estimations. ROC curve analysis was used to determine the AGR's optimal cut-off value. Kaplan-Meier plots were used to estimate RFS, CSS and OS, and the differences between the groups were tested using the log-rank test. Univariate and multivariate Cox regression models addressed RFS, CSS and OS. All the statistical analyses were carried out using JMP software, version 12 (SAS Institute, Cary, NC, USA). P-values <0.05 were considered statistically significant. Table 1 summarizes the patients' descriptive characteristics. The study cohort comprised 91 men and 33 women whose median age was 69 years (IQR 64-75 years). The median preoperative AGR was 1.53 (IQR 1.30-1.71), and the ROC analysis determined an optimal AGR cut-off value of 1.40 (sensitivity 70%, specificity 72%, area under the curve 0.745; Fig. S1 ). The study cohort was separated into two groups based on the optimal AGR cut-off value (1.40). The patients who had preoperative AGRs <1.40 comprised the low AGR group (n = 43, 35%), and the remaining patients (n = 81, 65%) comprised the high AGR group. A low AGR was significantly associated with being younger (P = 0.0108), a high Hgb (P = 0.0401), a high-grade tumor (P = 0.0049) and positive surgical margins (P = 0.0144).
Results
Baseline characteristics
The median follow-up interval after RNU was 55 months (IQR 28-76 months). Of the 124 patients, 20 patients (16%) died from UTUC, 22 patients (18%) had tumor recurrences and death from all causes occurred in 31 patients (25%) during follow up. The 5-year RFS, CSS and OS rates were 79.6%, 85.0% and 79.8%, respectively.
Prognostic factors
The univariate analyses showed that a low AGR was a significant predictor of poor RFS, CSS and OS (Figs 1-3) . The multivariate Cox regression analyses showed that a low AGR was an independent predictor of poor RFS (HR 3.758; 95% CI 1.579-9.419; P = 0.0028), CSS (HR 5.687; 95% CI 2.127-17.22; P = 0.0004) and OS (HR 3.124; 95% CI 1.474-6.826; P = 0.0030; Tables 2-4). The multivariate Cox regression analyses showed that advanced lymph node metastasis and lymphatic vessel invasion were independent prognostic factors for poor RFS, CSS and OS, and that an advanced age was an independent prognostic factor for poor OS, but not for RFS or CSS.
Discussion
The present study's findings showed that the preoperative AGR was significantly associated with RFS, CSS and OS in patients with UTUC after RNU. In addition, the AGR was an independent predictor of RFS, CSS and OS in the multivariate Cox regression models. ALB and GLB are the main protein components of the serum, and they are easily measured. ALB is produced by the liver and is used as a marker to evaluate a patient's nutritional status. The preoperative nutritional status can influence survival outcomes in patients with malignancies. 12 The preoperative nutritional index and the controlling nutritional status score have been described as predictors of survival in patients with UTUC. 11, 18 Nutritional deficiency is often associated with impaired immune responses, including cell-mediated immunity, phagocyte function, cytokine production and with reduced levels of many components of the complement system. 19 In addition to the nutritional status, the ALB level is associated with other factors, including the presence of an inflammatory response 20, 21 and the systemic inflammatory response. 22 Chronic inflammation is associated with the proliferation, development, progression and metastasis of tumor cells, as well as angiogenesis. Hypoalbuminemia might be caused by the production of cytokines, including IL-6, which modulate the production of ALB by the hepatocytes. The findings from studies have shown that micrometastases in the liver could induce the Kupffer cells to produce a variety of cytokines, which might modulate ALB synthesis by the hepatocytes. 23 Ku et al. reported that hypoalbuminemia is a prognostic marker in patients with UTUC. 13 The calculated GLB component contains large amounts of immune system-related proteins, including immunoglobulins, complement components, CRP, ILs and tumor necrosis factor. Gamma GLB, also known as immunoglobulins or antibodies, are secreted by the B cells of the adaptive immune system; hence, they play important roles in immunity. As a biomarker of systemic inflammation, an elevated CRP level has been considered as a prognostic factor in urological cancers. 24, 25 Evidence is accumulating that shows that the presence of a systemic inflammatory response is associated with poor survival in patients with a variety of malignancies. 26, 27 Indeed, a high preoperative GLB level was an unfavorable factor in patients with rectal cancer. 28 We believe that malnutrition and systemic inflammation have important effects on the oncological outcomes of patients with UTUC. Serum ALB and GLB levels are routinely measured preoperatively, and low ALB and high GLB levels indicate a poor nutritional status and severe chronic inflammation, respectively. The AGR reflects these two prognostic factors. We believe that the AGR is a more significant and accurate prognostic indicator. Several publications have described the AGR as a prognostic marker in patients with solid tumors (Table 5) . [14] [15] [16] In the present study, the ROC analysis determined that the ideal AGR cut-off value was 1.40, which was similar to the value reported from a previous investigation into esophageal cancer (1.41). 29 However, the ideal AGR cut-off value was 1.6 for patients with bladder cancer. 30 Therefore, an optimal cut-off value for the AGR threshold in patients with UTUC must be determined.
The present study had several limitations. First, this was a retrospective analysis that was undertaken at a single center and involved a relatively small patient cohort. Large-scale multicenter studies are necessary to validate our study's findings. In addition, this study did not evaluate the levels of many of the specific inflammatory markers, including the CRP and the inflammatory cytokine levels. Therefore, their associations with the AGR and the oncological outcomes in the patients with UTUC could not be examined.
The preoperative AGR is an independent predictor of OS, CSS and RFS in patients with UTUC that is inexpensive to measure. Furthermore, we believe that the AGR is a significant and useful prognostic indicator in patients with UTUC. 
